MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.0% of their position (3K shares) of NATERA, INC. on the open market
Open‑market sale worth $606.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/3/2026ACC: 0002010019-26-000011
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-3K
Net shares
Net seller
$606.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.05K
Price / share
$201.32
Trade value
$210.98K
% of position
0.7%
4/1/2026
150.88K→149.83K
Common Stock
Direct
Shares
−1K
Price / share
$202.36
Trade value
$202.36K
% of position
0.7%
4/1/2026
149.83K→148.83K
Common Stock
Direct
Shares
−952.00
Price / share
$203.31
Trade value
$193.55K
% of position
0.6%
4/1/2026
148.83K→147.88K
Total
Net shares
−3K
Net value
-$606.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −1.05K | $201.32 | $210.98K | 0.7% | 150.88K | 149.83K |
| Common Stock Direct | 4/1/2026 | S · Sale | −1K | $202.36 | $202.36K | 0.7% | 149.83K | 148.83K |
| Common Stock Direct | 4/1/2026 | S · Sale | −952.00 | $203.31 | $193.55K | 0.6% | 148.83K | 147.88K |
| Total | −3K | -$606.90K | ||||||
Derivative Transactions0
No derivative transactions reported